Clinical Trial Update: Study to Assess the Effectiveness of Existing Anti vascUlar Endothelial Growth Factor (Anti VEGF) in Patients With Wet Age-related Macular Degeneration (wAMD) (AURA)

View source ↗

Summary

This completed clinical trial (AURA) evaluated the effectiveness of existing anti-VEGF therapy for wet age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wet Age-related Macular Degeneration

Drugs mentioned

• existing anti-VEGF therapies (anti-VEGF therapy)

Snippet

Sponsor: Bayer | Conditions: Ophthalmology, Macular Degeneration | Status: COMPLETED